CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance proton therapy for cancer treatment by improving range verification methods. It focuses on using zinc-based contrast agents to increase the accuracy of dose distribution measurements during therapy.
In radiation therapy, proton therapy has a more favourable dose distribution than conventional radiotherapy with photons and electrons.
However, in order to fully exploit this dosimetric advantage, it would be required to verify the range of protons in the patient with mm accuracy.
The most used strategy for in-vivo range verification in protontherapy relies on positron emission tomography (PET) activation.
As they progress through the patient, proton beams undergo nuclear reactions than can pro…
SEDECAL MOLECULAR IMAGING SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
